Trial Assessing the Efficacy of a Short Course of Intravenous Antibiotic Followed by Oral Antibiotic in Uncomplicated Acute Diverticulitis
NCT00917592 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2023-09-28
Summary
Medical treatment of uncomplicated acute diverticulitis is not standardized and there is an enormous diversity in clinical practice. The investigators' aim was to demonstrate that uncomplicated diverticulitis can be managed with oral amoxicillin plus clavulanic acid with a short hospital admission.
Conditions
- Diverticulitis
Interventions
- DRUG
-
amoxicillin plus clavulanic acid
intravenous amoxicillin plus clavulanic acid 1 gr every 8 hours 48 hours followed by oral amoxicillin plus clavulanic acid 1 gr every 8 hours for 10 days
- DRUG
-
amoxicillin plus clavulanic acid
intravenous amoxicillin plus clavulanic acid for 7 days followed by oral antibiotic for 5 days
Sponsors & Collaborators
-
Corporacion Parc Tauli
collaborator OTHER -
Consorci Sanitari de Terrassa
lead OTHER
Principal Investigators
-
Yolanda Ribas, MD, PhD · Consorci Sanitari de Terrassa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-10-31
Countries
- Spain
Study Locations
More Related Trials
-
Effectiveness and Safety of Outpatient Treatment of Uncomplicated Acute Diverticulitis Without Antibiotics
NCT06517264 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
NCT02606032 ·Status: COMPLETED ·Phase: PHASE2
-
Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
NCT03794765 ·Status: COMPLETED ·Phase: PHASE2
-
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
NCT03469050 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis
NCT01847664 ·Status: COMPLETED ·Phase: PHASE2
-
Asacol Acute Diverticulitis(DIVA)Study
NCT00554099 ·Status: COMPLETED ·Phase: PHASE2
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
Secondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
NCT06687382 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
NCT01232595 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)
NCT03710694 ·Status: COMPLETED ·Phase: NA
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
Assessment of Patients With Acute Pouchitis Treated With Antibiotics
NCT05252273 ·Status: SUSPENDED
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702 ·Status: COMPLETED ·Phase: PHASE4
-
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
NCT03988855 ·Status: UNKNOWN ·Phase: PHASE2
-
Fecal Transplantation in Patients Colonic Diverticulitis
NCT06254625 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
NCT05750966 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
NCT03834038 ·Status: COMPLETED ·Phase: NA
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
NCT02214771 ·Status: COMPLETED
-
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
NCT06582264 ·Status: COMPLETED ·Phase: PHASE1